MedTrace Logo

Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia

NCT03173339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2017-08-25

No results posted yet for this study

Summary

This investigation is planned to compare the incidence and severity of postoperative sore throat according to the dose of remifentanil.

Conditions

  • Hip Arthroplasty

Interventions

PROCEDURE

Endotracheal intubation using laryngoscope

Endotracheal intubation was done using laryngoscope for general anesthesia.

DRUG

High remifentanil

Remifentanil was started as 0.25 mcg/kg/min. Remifentanil dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.05 mcg/kg/min.

DRUG

Low remifentanil

Remifentanil was administered as 0.1 mcg/kg/min.

DRUG

High sevoflurane

Sevoflurane was started as 0.5 MAC. Sevoflurane dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.2 %.

DRUG

Low sevoflurane

Sevoflurane was administered as 0.5 MAC.

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Principal Investigators

  • Hyun-Chang Kim, MD. Ph. D. · Keimyung University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2017-08-24
Completion
2017-08-24

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173339 on ClinicalTrials.gov